Latest venBio Partners LLC Stock Portfolio
venBio Partners LLC Performance:
2024 Q3: -14.58%YTD: -36.9%2023: 3.77%
Performance for 2024 Q3 is -14.58%, and YTD is -36.9%, and 2023 is 3.77%.
About venBio Partners LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, venBio Partners LLC reported an equity portfolio of $194.3 Millions as of 30 Sep, 2024.
The top stock holdings of venBio Partners LLC are PHVS, , HRMY. The fund has invested 40.9% of it's portfolio in PHARVARIS N V and 15.5% of portfolio in ALUMIS INC.
The fund managers got completely rid off ELEVATION ONCOLOGY INC (ELEV) stocks. They significantly reduced their stock positions in HARMONY BIOSCIENCES HLDGS IN (HRMY). venBio Partners LLC opened new stock positions in ARTIVA BIOTHERAPEUTICS INC.
The top stock holdings of venBio Partners LLC are PHVS, , HRMY. The fund has invested 40.9% of it's portfolio in PHARVARIS N V and 15.5% of portfolio in ALUMIS INC.
The fund managers got completely rid off ELEVATION ONCOLOGY INC (ELEV) stocks. They significantly reduced their stock positions in HARMONY BIOSCIENCES HLDGS IN (HRMY). venBio Partners LLC opened new stock positions in ARTIVA BIOTHERAPEUTICS INC.
venBio Partners LLC Annual Return Estimates Vs S&P 500
Our best estimate is that venBio Partners LLC made a return of -14.58% in the last quarter. In trailing 12 months, it's portfolio return was -18.15%.
New Buys
| Ticker | $ Bought |
|---|---|
| artiva biotherapeutics inc | 23,483,600 |
New stocks bought by venBio Partners LLC
Additions
Reductions
| Ticker | % Reduced |
|---|---|
| harmony biosciences hldgs in | -40.64 |
venBio Partners LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| elevation oncology inc | -6,572,490 |
venBio Partners LLC got rid off the above stocks
Sector Distribution
venBio Partners LLC has about 78.3% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 78.3 |
| Healthcare | 21.7 |
Market Cap. Distribution
venBio Partners LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 78.3 |
| SMALL-CAP | 12.7 |
| MICRO-CAP | 9.1 |
Stocks belong to which Index?
About 21.7% of the stocks held by venBio Partners LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 78.3 |
| RUSSELL 2000 | 21.7 |
venBio Partners LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of venBio Partners LLC
venBio Partners LLC has 6 stocks in it's portfolio. ALXO proved to be the most loss making stock for the portfolio. HRMY was the most profitable stock for venBio Partners LLC last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ALXO | alx oncology hldgs inc | 9.08 | 9,699,920 | 17,653,900 | unchanged | 0.00 | ||
| ELEV | elevation oncology inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| HRMY | harmony biosciences hldgs in | 12.65 | 614,594 | 24,583,800 | reduced | -40.64 | ||
| PHVS | pharvaris n v | 40.88 | 4,289,300 | 79,437,900 | unchanged | 0.00 | ||
| alumis inc | 15.53 | 2,826,050 | 30,182,200 | unchanged | 0.00 | |||
| artiva biotherapeutics inc | 12.08 | 1,519,970 | 23,483,600 | new | ||||
| acelyrin inc | 9.77 | 3,852,470 | 18,992,700 | unchanged | 0.00 | |||